{"schema_version":"secwatch.filing_event.v1","accession":"0001014739-24-000019","form_type":"8-K","ticker":"OPCH","cik":"0001014739","company_name":"Option Care Health, Inc.","filed_at":"2024-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.886500+00:00","generated_at":"2026-06-03T11:11:36.864702+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Option Care Health Q1 revenue up 12.8% to $1.146B; EPS $0.26; cash flow hit by cyber incident","bullets":["Net revenue $1,146.1M (+12.8% YoY); net income $44.8M ($0.26 EPS) vs $39.2M ($0.21) YoY.","Gross margin narrowed to 20.8% from 22.5%; adjusted EBITDA $98.3M (+4.8% YoY).","Cash flow from operations $(68.8)M vs $89.8M a year ago; cited Change Healthcare cyber incident.","Completed $40M in stock repurchases; full-year guidance: rev $4.65B-$4.8B, adj EBITDA $430M-$450M.","Received 2024 Gallup Exceptional Workplace Award."],"urls":{"canonical":"https://secwatch.observer/filing/0001014739-24-000019","json":"https://secwatch.observer/filing/0001014739-24-000019.json","markdown":"https://secwatch.observer/filing/0001014739-24-000019.md","text":"https://secwatch.observer/filing/0001014739-24-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1014739/000101473924000019/0001014739-24-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1014739/000101473924000019/bios-20240423.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T11:11:36.864702+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3a4b64732b0a43f4551279d6b945041ede18e313","claim":"Option Care Health, Inc. reported first quarter ended March 31, 2024 results: revenue $1,146.1 million, net income $44.8 million, EPS $0.26 earnings per share.","evidence_excerpt":"site infusion services, announced today financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results and Highlights • Net revenue of $1,146.1 million, up 12.8% compared to $1,015.8 million in the first quarter of 2023 • Gross profit of $238.5 million, or 20.8% of net revenue, up 4.1% compared to $229.0 million, or 22.5% of net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1014739/000101473924000019/0001014739-24-000019-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$1,146.1 million"},{"label":"Net income","value":"$44.8 million"},{"label":"EPS","value":"$0.26 earnings per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}